Haematology 2018

Two-Arm Parallel Phase 2 Clinical Trial of Atezolizumab with or without Low Dose Local Radiotherapy (2 x 2Gy) in Patients with Relapsed/Refractory Advanced Stage Follicular Lymphoma PI: M. Lia Palomba

Primary Objective

ORR for atezolizumab vs atezolizumab + single site IRT (2x2Gy) PFS and OS for atezolizumab vs atezolizumab + single site IRT (2x2Gy), Safety

Secondary Objectives

Exploratory objectives

Mandatory biopsies. Immune monitoring correlatives.